Is a vaccine needed against Candida albicans?
The development of a useful Candida vaccine is a distinct possibility despite the fact that individuals with a lifetime of commensal sensitization do not develop sterile immunity to the organism. An effective Candida vaccine would be invaluable in preventing hematogenously disseminated candidiasis, as well as mucocutaneous disease. This review is a discussion of our current understanding of the interplay between commensal and pathogenic forms of Candida albicans and approaches toward active and passive immunoprevention against candidiasis.
Mochon
A Brian
AB
Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. bmochon@tulane.edu
Cutler
Jim E
JE
D002176:Candida albicans / Q000276:immunology*; D002177:Candidiasis / Q000276:immunology / Q000517:prevention & control*; D005657:Fungal Vaccines; D006301:Health Services Needs and Demand; D006801:Humans
D005657:Fungal Vaccines